We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.6B
AUM Growth
-$392M
Cap. Flow
-$203M
Cap. Flow %
-12.69%
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74

Top Buys

1
DGX icon
Quest Diagnostics
DGX
+$24.5M
2
CHD icon
Church & Dwight Co
CHD
+$19.6M
3
ES icon
Eversource Energy
ES
+$18.2M
4
EXPE icon
Expedia Group
EXPE
+$17.6M
5
KMB icon
Kimberly-Clark
KMB
+$17.5M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
CAG icon
Conagra Brands
CAG
+$27M
3
SEE
Sealed Air
SEE
+$22.8M
4
LLY icon
Eli Lilly
LLY
+$22.1M
5
REG icon
Regency Centers
REG
+$20.3M

Sector Composition

1 Healthcare 28%
2 Consumer Staples 25.89%
3 Communication Services 10.3%
4 Technology 7.09%
5 Materials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTSH icon
251
Cognizant
CTSH
$21.1B
$183K 0.01%
2,706
+2,115
+358% +$162K
MNST icon
252
Monster Beverage
MNST
$97.7B
$183K 0.01%
+3,938
New +$171K
LNC icon
253
Lincoln National
LNC
$8.01B
$182K 0.01%
+3,902
New +$223K
ISRG icon
254
Intuitive Surgical
ISRG
$142B
$180K 0.01%
+896
New +$210K
LOW icon
255
Lowe's Companies
LOW
$121B
$169K 0.01%
970
– –
CCL icon
256
Carnival Corporation Ltd
CCL
$36.8B
$167K 0.01%
19,322
-369,665
-95% -$5.43M
AFL icon
257
Aflac
AFL
$62.6B
$165K 0.01%
2,989
+1,233
+70% +$72.8K
BMO icon
258
Bank of Montreal
BMO
$128B
$165K 0.01%
1,720
+635
+59% +$67.5K
CIEN icon
259
Ciena
CIEN
$55B
$162K 0.01%
3,551
+1,370
+63% +$71K
IDXX icon
260
Idexx Laboratories
IDXX
$45.4B
$162K 0.01%
463
+93
+25% +$37.9K
GPN icon
261
Global Payments
GPN
$22B
$160K 0.01%
+1,450
New +$183K
PAYX icon
262
Paychex
PAYX
$40.8B
$158K 0.01%
+1,388
New +$174K
BHC icon
263
Bausch Health
BHC
$1.84B
$157K 0.01%
+18,866
New +$264K
IFF icon
264
International Flavors & Fragrances
IFF
$19.8B
$153K 0.01%
1,286
– –
EXAS
265
DELISTED
Exact Sciences
EXAS
$151K 0.01%
3,824
-35,999
-90% -$1.92M
PFG icon
266
Principal Financial Group
PFG
$24.4B
$151K 0.01%
2,260
+1,044
+86% +$73.4K
BNS icon
267
Scotiabank
BNS
$110B
$150K 0.01%
2,536
+527
+26% +$34.2K
SPG icon
268
Simon Property Group
SPG
$74.1B
$150K 0.01%
1,577
– –
KLAC icon
269
KLA
KLAC
$287B
$147K 0.01%
+4,610
New +$155K
SCHW
270
Charles Schwab
SCHW
$179B
$143K 0.01%
2,269
+1,997
+734% +$138K
RMD icon
271
ResMed
RMD
$29.4B
$142K 0.01%
676
– –
EQR icon
272
Equity Residential
EQR
$26.2B
$138K 0.01%
1,915
– –
MSCI icon
273
MSCI
MSCI
$46.4B
$138K 0.01%
+336
New +$146K
DFS
274
DELISTED
Discover Financial Services
DFS
$136K 0.01%
+1,443
New +$154K
MOH icon
275
Molina Healthcare
MOH
$11.7B
$136K 0.01%
+488
New +$147K
9 10
11
12 13

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2022 Portfolio in Review

As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.

  • TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
  • TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
  • TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
  • TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
  • TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
  • TOBAM opened 74 new positions and closed 74 in Q2 2022.
  • TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.